[ad_1]
Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
[ad_2]
Funding lifelines: How to cross the 'valley of death'
Related Posts
Alibaba launches new AI tools to support global e-commerce businesses
[ad_1] Summary China’s Alibaba Group has introduced new artificial intelligence tools through its international commerce arm to help small businesses manage cross-border e-commerce operations, as […]
Italy’s angels & incubators and venture capital weekly roundup. News from Nando, Quido, Vertis Maia Ventures, CDP Venture Capital, Fondo Piemonte Next, Club degli Investitori, La4G – Luiss Alumni 4 Growth, EMBA Capital Partners, SevenData, Edrom, and more
[ad_1] In 2025, startups and scaleups based in Italy or with Italian founders secured 293 rounds (287 in 2024) worth in the region of 5.9 billion euros […]
VCs look to glam up portfolio with fashion and lifestyle investments
[ad_1] The new fiscal year is likely to see a pickup in deal activity across the fashion and lifestyle segment, with several early-to-mid-stage brands and […]